In an era marked by global unrest, regulatory complexities, and a shifting market landscape, companies must remain diligent in their trade compliance procedures and stay apprised of changes in the law.
TC Trade Alerts will serve as a central resource for identifying the policy changes, executive orders, and necessary information and context regarding government actions affecting international trade.
See below for more information on the last TC Trade Alerts. If you have any questions about how this affects your business, please don't hesitate to contact one of our attorneys.
Additional Resources
Trade Compliance Handbook | Checklists of Foreign Countries Subject to Sanctions | Our International Trade Practice
| THOMPSON COBURN TRADE ALERT – IMPORTS | |
| HEADLINE | Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients |
| DATE | April 16, 2025 |
| AGENCY | Department of Commerce; Trump Administration |
| EFFECTIVE DATES | Deadline to Submit Comments in Docket No. 250414-0065 – May 7, 2025 (21 Days after Publication Date) |
| BACKGROUND | On April 1, 2025, the Trump Administration directed the Secretary of Commerce to conduct a 232 investigation into pharmaceuticals, pharmaceutical ingredients, and their derivative products to determine whether such imports impair the national security of the United States. |
| DETAILS | The Department of Commerce's Bureau of Industry and
Security is seeking written comments, data, and information related
to the national security impacts of pharmaceuticals, pharmaceutical
ingredients, and their derivative products.
The Department is specifically interested in receiving comments and information regarding the following areas:
Please refer to the Notice linked below for filing instructions. Comments can be submitted electronically at www.regulations.gov, ID: BIS-2025-0022, and all comments should refer to XRIN 0694-XC120 |
| BASIS | Section 232 of the Trade Expansion Act of 1962; part 705 of the National Security Industrial Base Regulations (15 CFR parts 700 through 709) |
| CITE | Federal Register: Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients |
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
